A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload referred to as an NMT inhibitor. Novartis ...
Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload referred to as an NMT inhibitor. Novartis ...
AbbVie is diversifying its oncology pipeline, paying $650 million for a clinical-stage drug that goes after two targets to fight ...
As with most rare diseases, the market for hereditary angioedema drugs is small. It’s also relatively crowded, served by several ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.